6.5 Million Dollar Jury Verdict in Actos® Trial
On April 26, 2013, a Los Angeles jury returned a verdict of $6.5 million to Jack Cooper, who was diagnosed with terminal bladder cancer after taking Actos® – manufactured by Takeda – for more than two years. The jury also awarded $1.5 million to Mr. Cooper’s wife for her loss of consortium claim. After more than a week of deliberations, the jury found that Takeda failed to adequately warn of the dangers of Actos® and that Actos® was a substantial factor in Mr. Cooper’s injuries.
Actos® is a prescription medication manufactured by Takeda which is prescribed to control glucose (blood sugar) in adults with Type 2 diabetes. In June 2011, the FDA issued a drug safety alert warning that the use of Actos® for more than one year may be associated with an increased risk of bladder cancer.
If you or a loved one developed bladder cancer while taking Actos®, contact the experienced pharmaceutical attorneys at Schlichter, Bogard & Denton LLP toll-free at 1-800-873-5297. We will confidentially evaluate your case for free and without any obligation.
Legal Disclaimer: The choice of a lawyer is an important decision and should not be based solely on advertisements. The case mentioned does not guarantee and/or predict outcomes in future cases.